Skip to content

Clinical trials

Completed Phase 3 Heart Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 3 Status: Completed Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20025
20036
20047
20054
20066
20071
20084
20093
20104
20114
20122
20132
20161
20172
20185
20191
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed165

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)69
University of Washington6
Carelon Research4
Acusphere3
Duke University3
Organon and Co3
Stanford University3
University of Minnesota3
University of Pittsburgh3
Biosense Webster, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases165
Cardiovascular Diseases112
Coronary Disease62
Myocardial Ischemia54
Myocardial Infarction35
Hypertension27
Vascular Diseases21
Arrhythmias, Cardiac17
Coronary Artery Disease17
Heart Failure17

Trials

Showing 1 to 25 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.